Pfizer-BioNTech Covid-19 Booster licensed for sixteen- and 17-year-Olds

Scientists and vaccine makers are investigating Omicron, a Covid-19 variant with round 50 mutations, that has been detected in lots of countries after spreading in southern Africa. here's what we know as the U.S. and others implement commute restrictions. image: Fazry Ismail/EPA-EFE/Shutterstock

U.S. fitness regulators cleared the Covid-19 booster from Pfizer Inc. and accomplice BioNTech SE for use in sixteen- and 17-year-olds, widening eligibility because the worrisome Omicron variant spreads around the world.

The meals and Drug Administration determination allows the teenagers to get hold of a third dose of the shot at least six months after their basic vaccination series.